COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
zeba siddiqui

Zeba Siddiqui

Sun Pharma expects Ranbaxy costs to hit 2016 revenue

by Zeba Siddiqui |Jul 20, 2015

Sun Pharma said its profit could be hurt due to "certain expenses/charges arising out of integration as well as remedial actions."

Photo: Reuters

Government extends price caps to 39 more medicines

by Zeba Siddiqui |Jul 16, 2015

The move impacts multinational drugmakers, like Abbott Laboratories and GlaxoSmithKline, and a number of local firms, including Lupin, Cadila Healthcare and, all of whom sell drugs added to the li...

Govt plans regulator for medical device industry

by Zeba Siddiqui |Jun 12, 2015

The policy document, welcomed by many in the industry despite concerns over a lack of detail, also outlines plans to boost local manufacturing and reduce reliance on imports.

More than a third of India's 2.1 million HIV/AIDS patients depend on getting their daily antiretrovirals for free from state-run distribution centres.

India scraps import duties on AIDS drugs to battle shortage

by Zeba Siddiqui |Jun 11, 2015

More than a third of India's 2.1 million HIV/AIDS patients depend on getting their daily antiretrovirals for free from state-run distribution centres.

An exterior view of the Fortis Memorial Hospital is pictured at Gurgaon on the outskirts of New Delhi, India, May 20, 2015. Photo: Reuters

Private hospitals take luxury route to growth

by Zeba Siddiqui |May 28, 2015

"The fact that you actually come for surgery or medical treatment would be an incidental part of the experience," ABV Group Chief Executive Advet Bhambhani told Reuters.

Mahindra, which is the world's largest maker of tractors by volume, said the deal would help both companies cut cost and improve their supply chain.

M&M to buy 33 per cent stake in Mitsubishi Heavy's farm machinery unit

by Zeba Siddiqui |May 21, 2015

Mahindra and Mahindra said on Thursday it would buy a 33 per cent voting stake in the agricultural machinery-making unit of Mitsubishi Heavy Industries for $25 million.

The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.

SC bars Glenmark from selling copies of Merck diabetes drugs: Sources

by Zeba Siddiqui |May 15, 2015

The court has, however, allowed Glenmark to continue to sell existing inventory, the sources said.

Ranbaxy filed "grossly inadequate" applications seeking approval for its drugs. (Reuters)

Ranbaxy sued for manipulating USFDA rules to gain market exclusivity

by Zeba Siddiqui |May 15, 2015

Ranbaxy filed "grossly inadequate" applications seeking approval for its drugs and deceived the FDA into granting approvals and giving the company market exclusivity.

India's reputation as a reliable supplier of cheap generic medicines has taken a hit. (Reuters)

Two-thirds of drug combinations sold in India lack regulatory approval: Study

by Zeba Siddiqui |May 13, 2015

Almost two-thirds of the drug combinations widely sold in India to fight pain, depression, and psychotic conditions lack the necessary regulatory approvals, a study published on Tuesday shows.

Dilip Shanghvi, who with his family controls Sun Pharmaceutical, is India's second richest man according to Forbes magazine. (Photo: Reuters)

Sun Pharmaceutical may spend up to $7 bn on mergers and acquisitions, say bankers

by Sumeet Chatterjee |Apr 28, 2015

Investment bankers say on the radar are US and European companies that develop biosimilars - cheaper copies of biotech drugs.